Journal article

Conflicting immunohistochemistry and metabolic imaging parameters in adenocarcinoma lung showing elevated serum CA 19-9 with immunonegative TTF1 and Napsin A

SSSweta Sinha SSSweta Sinha VYVijaya Aditya Yadaraju VYVijaya Aditya Yadaraju PAPraveen Adusumilli PAPraveen Adusumilli MBMuralidhar Bora MBMuralidhar Bora VSVatturi Venkata Satya VSVatturi Venkata Satya
Year2020
Volume7
Issue1
Pages186-190

Abstract

Lung carcinoma is the most common and lethal malignancy in men. Non-small cell lung carcinoma is more
aggressive than small cell lung carcinoma and often presents in advanced stage with metastasis. Cytology,
histopathology, immunohistochemistry and metabolic imaging play an important role in classifying lung
carcinomas. TTF 1 and Napsin A are highly sensitive and specific for adenocarcinoma lung, but the
sensitivity and specificity decreases in high grade tumours. Elevated serum CA 19-9 tumour marker is
not always related to pancreatico-biliary adenocarcinomas. It can be positive in adenocarcinoma lung and
its elevation confers poor prognosis. Quintessential role of metabolic imaging like 18F-FDG PET CT scan
in high grade carcinomas is well known. With the advent of targeted therapy, molecular and receptor studies
of EGFR, ROS 1 and ALK gene rearrangement becomes mandatory in all lung adenocarcinomas. Hence,
both oncologist and pathologist should diagnose advanced stage tumours without bias with good clinical,
radiological and pathological correlation.

Keywords: Lung adenocarcinoma, Immunohistochemistry, CA 19-9, TTF1, Napsin A, Metabolic imaging.

Cite this article

Citation data